DPL LLC Initiates Consent Solicitation to Amend Bond Terms
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy AES?
Source: Newsfilter
- Consent Solicitation Launched: DPL LLC has initiated a consent solicitation aimed at amending the terms of its 4.35% Senior Notes due 2029, to ensure the upcoming merger is not classified as a 'Change of Control'.
- Merger Agreement Context: This solicitation is linked to the merger agreement signed by AES on March 1, 2026, which is led by an investor consortium and is expected to close in late 2026 or early 2027, potentially impacting bond ratings.
- Consent Fee Incentive: DPL is offering a consent fee of $1.00 per $1,000 of notes held to encourage holders to submit their consent by March 11, 2026; if the requisite majority is not obtained, no fee will be paid.
- Amendment Details: Proposed amendments include not classifying the merger as a 'Change of Control' and allowing GIP and EQT to be 'Permitted Holders', with these changes becoming effective only upon the completion of the merger, thereby protecting the interests of bondholders.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AES?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AES
Wall Street analysts forecast AES stock price to rise
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 14.150
Low
15.00
Averages
18.25
High
24.00
Current: 14.150
Low
15.00
Averages
18.25
High
24.00
About AES
The AES Corporation is an energy company. The Company operates in four segments: Renewables, Utilities, Energy Infrastructure, and New Energy Technologies. The Renewables segment include solar, wind, energy storage, and hydro generation facilities. The Utilities segment includes AES Indiana, AES Ohio, and AES El Salvador regulated utilities and their generation facilities. The Energy Infrastructure segment includes natural gas, liquefied natural gas (LNG), coal, pet coke, diesel, and oil generation facilities, and its businesses in Chile, which have a mix of generation sources, including renewables. The New Energy Technologies segment includes investments in Fluence, Uplight, Maximo and other initiatives. It has two lines of business: Generation, which owns and/or operates power plants to generate and sell power to customers and Utilities that own and/or operate utilities to generate or purchase, distribute, transmit and sell electricity to end-user customers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ten Large-Cap Stocks with Worst Performance Last Week
- Lumentum Holdings Decline: Lumentum Holdings Inc. saw a 24.65% drop this week, despite its upcoming inclusion in the S&P 500 on March 23, 2026, indicating a significant loss of investor confidence in its future performance.
- Celsius Holdings Struggles: Celsius Holdings, Inc. experienced a 17.86% decline this week, reflecting investor concerns over its profitability, particularly in a challenging overall market environment.
- Pressure on Precious Metals: First Majestic Silver Corp. dropped 17.69% this week, as rising dollar strength and yields exerted greater market pressure on precious metal companies amid escalating conflict in the Middle East.
- Carnival Corporation Impacted: Carnival Corporation's stock fell 10.45% this week, as coordinated U.S. and Israeli strikes on Iranian targets heightened geopolitical risks, leading to diminished investor confidence in cruise operators.
See More
Multiple Companies Announce Significant Acquisition Deals
- Increased Acquisition Offer: Diana Shipping raised its offer for Genco Shipping to $23.50 per share, indicating strong interest in the dry bulk shipping market, which could enhance its market share and competitiveness.
- Massive Cash Deal: Day One Biopharmaceuticals agreed to be acquired by French pharmaceutical group Servier in an all-cash deal worth nearly $2.5 billion, significantly strengthening Servier's position in the cancer drug market.
- Potential Acquisition Impact: Rohm Co's shares surged in Tokyo trading following Denso's takeover approach valuing the chipmaker at around ¥1.3 trillion ($8.3 billion), reflecting positive market sentiment towards semiconductor industry consolidation.
- Strategic Asset Sale: IAC agreed to sell Care.com to Pacific Avenue Capital Partners for approximately $320 million, with the deal expected to close in the first half of 2026, aimed at optimizing IAC's asset portfolio and focusing on core operations.
See More
Morgan Stanley Downgrades AES to Equal Weight Amid Equity Concerns
- Rating Downgrade: Morgan Stanley downgraded AES from Overweight to Equal Weight with a price target cut from $23 to $15, reflecting concerns over potential equity needs by 2026, which could negatively impact the company's future growth.
- Capital Access Bottleneck: AES has consistently cited capital access as the biggest bottleneck to accelerating growth in the attractive U.S. renewables and utilities sectors, and the analyst believes that a transaction with a large sponsor shareholder makes strategic sense in this context.
- Dividend and Equity Risks: The transaction avoids the need to materially reduce or eliminate dividends before 2026; however, the analyst notes that this conveys a more negative message compared to the current financial plan, raising investor concerns about future dividends and equity issuance.
- Market Reaction: AES shares are currently trading at about a 5% discount to the deal price, and the analyst suggests that if the transaction does not proceed, the stock could trade significantly below current levels, reflecting negative market expectations regarding potential equity needs.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Merger Investigation: Halper Sadeh LLC is investigating the merger between Rallybio Corporation and Candid Therapeutics, Inc., with Rallybio shareholders expected to own approximately 3.65% of the combined entity, potentially impacting shareholder rights and future returns.
- Legal Rights: The firm encourages shareholders of Rallybio and VerifyMe, Inc. to reach out to discuss their rights and options, indicating the legal risks and potential financial losses shareholders may face during the merger process.
- Cash Acquisition: AES Corporation is being sold for $15.00 per share in cash to a consortium led by Global Infrastructure Partners and EQT Infrastructure VI fund, with Halper Sadeh LLC potentially seeking increased consideration or other compensation, reflecting a focus on shareholder interests.
- Investor Protection: Halper Sadeh LLC represents investors globally, committed to combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors in the past, underscoring its importance in safeguarding investor rights.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these firms.
- Market Reaction Insight: While specific company names were not mentioned, changes in analyst ratings typically influence investor decisions, potentially leading to price volatility in the affected stocks.
- Investor Focus: As investors consider buying TTD stock, analysts' opinions will serve as a crucial reference, especially in the current market environment where such insights may impact short-term investment strategies.
- Rating Change Transparency: To view the complete picture of all analyst rating changes, investors can visit the analyst ratings page, ensuring they stay updated with the latest market information and analyses.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- OKTA Stock Outlook: Analysts' perspectives on OKTA stock have garnered attention, prompting investors to consider these rating changes when contemplating purchases for more informed investment choices.
- Impact of Rating Changes: Upgrades or downgrades in ratings can directly affect stock prices, necessitating that investors closely monitor these changes to seize market opportunities.
- Comprehensive Analysis View: For a complete overview of all analyst rating changes, including upgrades and downgrades, it is recommended to visit our analyst ratings page for more detailed information and data.
See More
Ten Large-Cap Stocks with Worst Performance Last Week
- Lumentum Holdings Decline: Lumentum Holdings Inc. saw a 24.65% drop this week, despite its upcoming inclusion in the S&P 500 on March 23, 2026, indicating a significant loss of investor confidence in its future performance.
- Celsius Holdings Struggles: Celsius Holdings, Inc. experienced a 17.86% decline this week, reflecting investor concerns over its profitability, particularly in a challenging overall market environment.
- Pressure on Precious Metals: First Majestic Silver Corp. dropped 17.69% this week, as rising dollar strength and yields exerted greater market pressure on precious metal companies amid escalating conflict in the Middle East.
- Carnival Corporation Impacted: Carnival Corporation's stock fell 10.45% this week, as coordinated U.S. and Israeli strikes on Iranian targets heightened geopolitical risks, leading to diminished investor confidence in cruise operators.
See More
Multiple Companies Announce Significant Acquisition Deals
- Increased Acquisition Offer: Diana Shipping raised its offer for Genco Shipping to $23.50 per share, indicating strong interest in the dry bulk shipping market, which could enhance its market share and competitiveness.
- Massive Cash Deal: Day One Biopharmaceuticals agreed to be acquired by French pharmaceutical group Servier in an all-cash deal worth nearly $2.5 billion, significantly strengthening Servier's position in the cancer drug market.
- Potential Acquisition Impact: Rohm Co's shares surged in Tokyo trading following Denso's takeover approach valuing the chipmaker at around ¥1.3 trillion ($8.3 billion), reflecting positive market sentiment towards semiconductor industry consolidation.
- Strategic Asset Sale: IAC agreed to sell Care.com to Pacific Avenue Capital Partners for approximately $320 million, with the deal expected to close in the first half of 2026, aimed at optimizing IAC's asset portfolio and focusing on core operations.
See More
Morgan Stanley Downgrades AES to Equal Weight Amid Equity Concerns
- Rating Downgrade: Morgan Stanley downgraded AES from Overweight to Equal Weight with a price target cut from $23 to $15, reflecting concerns over potential equity needs by 2026, which could negatively impact the company's future growth.
- Capital Access Bottleneck: AES has consistently cited capital access as the biggest bottleneck to accelerating growth in the attractive U.S. renewables and utilities sectors, and the analyst believes that a transaction with a large sponsor shareholder makes strategic sense in this context.
- Dividend and Equity Risks: The transaction avoids the need to materially reduce or eliminate dividends before 2026; however, the analyst notes that this conveys a more negative message compared to the current financial plan, raising investor concerns about future dividends and equity issuance.
- Market Reaction: AES shares are currently trading at about a 5% discount to the deal price, and the analyst suggests that if the transaction does not proceed, the stock could trade significantly below current levels, reflecting negative market expectations regarding potential equity needs.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Merger Investigation: Halper Sadeh LLC is investigating the merger between Rallybio Corporation and Candid Therapeutics, Inc., with Rallybio shareholders expected to own approximately 3.65% of the combined entity, potentially impacting shareholder rights and future returns.
- Legal Rights: The firm encourages shareholders of Rallybio and VerifyMe, Inc. to reach out to discuss their rights and options, indicating the legal risks and potential financial losses shareholders may face during the merger process.
- Cash Acquisition: AES Corporation is being sold for $15.00 per share in cash to a consortium led by Global Infrastructure Partners and EQT Infrastructure VI fund, with Halper Sadeh LLC potentially seeking increased consideration or other compensation, reflecting a focus on shareholder interests.
- Investor Protection: Halper Sadeh LLC represents investors globally, committed to combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors in the past, underscoring its importance in safeguarding investor rights.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these firms.
- Market Reaction Insight: While specific company names were not mentioned, changes in analyst ratings typically influence investor decisions, potentially leading to price volatility in the affected stocks.
- Investor Focus: As investors consider buying TTD stock, analysts' opinions will serve as a crucial reference, especially in the current market environment where such insights may impact short-term investment strategies.
- Rating Change Transparency: To view the complete picture of all analyst rating changes, investors can visit the analyst ratings page, ensuring they stay updated with the latest market information and analyses.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- OKTA Stock Outlook: Analysts' perspectives on OKTA stock have garnered attention, prompting investors to consider these rating changes when contemplating purchases for more informed investment choices.
- Impact of Rating Changes: Upgrades or downgrades in ratings can directly affect stock prices, necessitating that investors closely monitor these changes to seize market opportunities.
- Comprehensive Analysis View: For a complete overview of all analyst rating changes, including upgrades and downgrades, it is recommended to visit our analyst ratings page for more detailed information and data.
See More
